Immunotherapy Advances in the Management of Nonmelanoma Skin Cancers

Review the latest in the use of immunotherapies in the management of basal cell carcinoma, cutaneous squamous cell carcinoma, and Merkel cell carcinoma and best practices in identifying and managing immune-related adverse events associated with immunotherpies in a focused text module and expert commentary.


Program Content

No activities added yet

No activities added yet


Neoadj Cemiplimab in cSCC
What You Need to Know About the Use of Neoadjuvant Cemiplimab in Advanced cSCC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2023

View Activity


cover img faculity

Crystal Aguh, MD

Associate Professor
Department of Dermatology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC


Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc